Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RTI SURGICAL, INC.RTIX · Entity 159205 | VP Corporate Controller | March 08, 2019 | March 11, 2019 |
| SURGALIGN HOLDINGS, INC.SRGA · Entity 109633 | VP, Chief Accounting Officer | September 25, 2020 | April 14, 2021 |
| Tempus AI, Inc.TEM · Entity 1545 | Chief Accounting Officer | August 18, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RTI SURGICAL, INC.
Report date March 08, 2019 · Filed March 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 18,734 · Balance 0 F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers. F4: Total includes 16,734 shares of restricted stock that will vest on; 2,717 shares on each of 9/25/2019 and 9/25/2020 and 2,718 shares on 9/25/2021, 2,861 shares on each of 2/26/2020 and 2/26/2021 and 2,860 shares on 2/26/2022. |
| Option to purchase common stock $.001 par valueSEC Table II · derivative / convertible security · Conversion / exercise price $4.60 · Expires 2028-09-25 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-08 · Grant · Acquired 17,202 · Balance 0 F5: The options will become exercisable as to 3,440 shares on each of 9/25/2019, 9/25/2020, 9/25/2021 and 3,441 shares on each of 9/25/2022 and 9/25/2023. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc."
F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger.
F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers.
F4: Total includes 16,734 shares of restricted stock that will vest on; 2,717 shares on each of 9/25/2019 and 9/25/2020 and 2,718 shares on 9/25/2021, 2,861 shares on each of 2/26/2020 and 2/26/2021 and 2,860 shares on 2/26/2022.
F5: The options will become exercisable as to 3,440 shares on each of 9/25/2019, 9/25/2020, 9/25/2021 and 3,441 shares on each of 9/25/2022 and 9/25/2023.
SURGALIGN HOLDINGS, INC.
Report date September 25, 2020 · Filed April 14, 2021 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,561 |
Reported balance
After 2020-09-25 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2020-09-25 · Tax withholding · Disposed 797 · Balance 79,561 F1: The Form 4 filed on 9/29/2020 for shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock erroneously reported 2,717 RSUs in column 4. The purpose of this amendment is to correct the total underlying shares in column 5. |
Filing footnotes · ownership attribution and instrument terms
F1: The Form 4 filed on 9/29/2020 for shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock erroneously reported 2,717 RSUs in column 4. The purpose of this amendment is to correct the total underlying shares in column 5.
Tempus AI, Inc.
Report date August 18, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 67,866 |
Reported balance
After 2026-08-18 transaction · row 1
1 source rowRow 1 · 2026-08-18 · Sale · Disposed 6,175 · Balance 67,866 F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $49.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $49.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2026 Filed Aug 21, 2026 01:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 6,175 | $49.61 | $306,341.75 |
DisclosureSEC source: 0001754464-26-000016 · form4-08202026_090801.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,866 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $49.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2026 Filed May 21, 2026 21:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 4,116 | $44.07 | $181,392.12 |
DisclosureSEC source: 0001754464-26-000012 · form4-05212026_050501.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,041 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.65 to $44.46 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:30 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001754464-26-000007 · form4-05062026_040512.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,157 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in twelve equal quarterly installments commencing on November 15, 2026. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 23:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 12,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001754464-26-000005 · form4-02202026_060208.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,157 F3 · shares: Represents (i) 2,998 fully vested restricted stock units, comprising the Reporting Person's 2025 bonus award, and (ii) 10,000 shares certified as earned with respect to an award of performance-based stock units ("PSUs") granted on August 7, 2025. The Issuer's Board of Directors certified the achievement of the applicable performance metrics and goals on February 20, 2026 and the PSUs will vest, in accordance with their terms, on August 15, 2026. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 23:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 2,902 | $59.05 | $171,363.10 |
DisclosureSEC source: 0001754464-26-000005 · form4-02202026_060208.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,159 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.71 to $59.38 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2025 Filed Nov 21, 2025 00:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 573 | $66.15 | $37,903.95 |
DisclosureSEC source: 0001754464-25-000007 · form4-11202025_071102.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,061 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.78 to $66.62 inclusive. Read SEC document |
| November 18, 2025 Filed Nov 21, 2025 00:05 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,261 | $65.26 | $82,292.86 |
DisclosureSEC source: 0001754464-25-000007 · form4-11202025_071102.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,634 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.7216 to $65.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 46 | $75.61 | $3,478.06 |
DisclosureSEC source: 0001415889-25-022584 · form4-08212025_040801.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,895 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 20:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,858 | $74.63 | $138,662.54 |
DisclosureSEC source: 0001415889-25-022584 · form4-08212025_040801.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,941 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.36 to $75.2673 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 20, 2025 Filed May 23, 2025 00:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,819 | $63.29 | $115,124.51 |
DisclosureSEC source: 0001415889-25-014298 · form4-05222025_080501.xml · nonDerivative · entry 3 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,799 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Read SEC document |
| May 20, 2025 Filed May 23, 2025 00:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 6 | $63.70 | $382.20 |
DisclosureSEC source: 0001415889-25-014298 · form4-05222025_080501.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,618 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| May 20, 2025 Filed May 23, 2025 00:00 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 4,248 | $63.21 | $268,516.08 |
DisclosureSEC source: 0001415889-25-014298 · form4-05222025_080501.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,624 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.675 to $63.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2025 Filed May 2, 2025 22:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011864 · form4-05022025_060502.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,872 F2 · shares: Represents an RSU grant. One-third of the RSUs will vest on March 15, 2026 and one-twelfth will vest in equal quarterly installments thereafter. Read SEC document |
| February 24, 2025 Filed May 2, 2025 22:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 4,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011864 · form4-05022025_060502.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,872 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs are fully vested. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 00:55 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,682 | $80.00 | $134,560.00 |
DisclosureSEC source: 0001415889-25-004979 · form4-02202025_070208.xml · nonDerivative · entry 3 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,500 F4 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 00:55 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 68 | $82.36 | $5,600.48 |
DisclosureSEC source: 0001415889-25-004979 · form4-02202025_070208.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,182 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.14 to $82.51 inclusive. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 00:55 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 750 | $81.83 | $61,372.50 |
DisclosureSEC source: 0001415889-25-004979 · form4-02202025_070208.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,250 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.1302 to $82.13 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) and (3). Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 21:32 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 6,059 | $80.00 | $484,720.00 |
DisclosureSEC source: 0001415889-25-004115 · form4-02142025_090219.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,000 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:34 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 2,320 | $71.00 | $164,720.00 |
DisclosureSEC source: 0001415889-25-003387 · form4-02072025_100231.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,059 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:34 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 1,858 | $67.57 | $125,545.06 |
DisclosureSEC source: 0001415889-25-003387 · form4-02072025_100231.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,379 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.085 to $68.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2025 Filed Feb 1, 2025 02:26 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 13,770 | $60.00 | $826,200.00 |
DisclosureSEC source: 0001415889-25-002620 · form4-02012025_020213.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,237 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 01:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | SaleClass A Common Stock | 339 | $40.23 | $13,637.97 |
DisclosureSEC source: 0001415889-24-029794 · form4-12182024_081201.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,007 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:15 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026132 · form4-11052024_041121.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,346 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs will vest in sixteen equal quarterly installments beginning on January 15, 2025. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 01:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | Tax withholdingClass A Common Stock | 13,654 | $37.00 | $505,198.00 |
DisclosureSEC source: 0001415889-24-017310 · form4-06172024_090620.xml · nonDerivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,346 F2 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 13, 2024 Filed Jun 18, 2024 01:45 UTC | Tempus AI, Inc. TEM · Entity 1545 | GrantClass A Common Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-017310 · form4-06172024_090620.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · shares: Consists of previously granted restricted stock units ("RSUs") for which the liquidity event-based condition was satisfied upon the effectiveness of the registration statement on Form S-1 filed by the Issuer in connection with the Issuer's initial public offering. Certain of the RSUs remain subject to service-based vesting conditions, as follows: (i) 14,000 RSUs vest in eight equal quarterly installments commencing on August 1, 2024; (ii) 8,250 RSUs vest in 11 equal quarterly installments commencing on August 15, 2024; (iii) 12,000 RSUs vest in 16 equal quarterly installments commencing on June 15, 2024; and (iv) 10,000 RSUs vest one-third on March 15, 2025 with the remainder vesting in eight substantially equal quarterly installments commencing on June 15, 2025. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 14:11 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | Tax withholdingCommon Stock | 2,717 | $1.92 | $5,216.64 |
DisclosureSEC source: 0001209191-20-052279 · doc4.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,641 F1 · shares: Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| September 25, 2020 Filed Apr 14, 2021 19:11 UTC Amendment | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | Tax withholdingCommon Stock | 797 | $1.92 | $1,530.24 |
DisclosureSEC source: 0001209191-21-026630 · doc4a.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,561 F1 · shares: The Form 4 filed on 9/29/2020 for shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock erroneously reported 2,717 RSUs in column 4. The purpose of this amendment is to correct the total underlying shares in column 5. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 17:20 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantOption to purchase common stock · Derivative | 44,006 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001209191-20-043575 · doc4.xml · derivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,456 Underlying: Common Stock · 44,006 shares Expires 2030-07-21 F2 · derivative.exercise_date: The options will become exercisable as to 8,802 shares on 2/26/2021 and 8,801 shares on each of 2/26/2022, 2/26/2023, 2/26/2024 and 2/26/2025. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 17:20 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantCommon Stock | 18,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043575 · doc4.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,358 F1 · shares: The Restricted Stock Award will become vested as to 6,167 shares on 2/26/2021 and 6,166 shares on each of 2/26/2022 and 2/26/2023. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 18:52 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantOption to purchase common stock $.001 par value · Derivative | 102,248 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001209191-20-040953 · doc4.xml · derivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,450 Underlying: Common Stock · 102,248 shares Expires 2030-07-02 F2 · derivative.exercise_date: The options will become exercisable as to 20,450 shares on each of 2/26/2021, 2/26/2022 and 2/26/2023 and 20,449 on each of 2/26/2024 and 2/26/2025. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 18:52 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantCommon Stock | 43,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040953 · doc4.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,859 F1 · shares: The Restricted Stock Award will become vested as to 14,375 shares on each of 2/26/2021, 2/26/2022 and 2/26/2023. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 15:38 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantOption to purchase common stock $.001 par value · Derivative | 17,202 | $4.60 Strike: $4.60 | $79,129.20 |
DisclosureSEC source: 0001100441-19-000012 · primary_doc.xml · derivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,202 shares Expires 2028-09-25 F5 · derivative.exercise_date: The options will become exercisable as to 3,440 shares on each of 9/25/2019, 9/25/2020, 9/25/2021 and 3,441 shares on each of 9/25/2022 and 9/25/2023. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 15:38 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | Disposition to issuerCommon Stock | 18,734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001100441-19-000012 · primary_doc.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2 · price: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3 · price: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers. F4 · price: Total includes 16,734 shares of restricted stock that will vest on; 2,717 shares on each of 9/25/2019 and 9/25/2020 and 2,718 shares on 9/25/2021, 2,861 shares on each of 2/26/2020 and 2/26/2021 and 2,860 shares on 2/26/2022. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:49 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantOption to purchase common stock $.001 par value · Derivative | 17,202 | $4.60 Strike: $4.60 | $79,129.20 |
DisclosureSEC source: 0001760173-19-000027 · primary_doc.xml · derivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,202 Underlying: Common Stock · 17,202 shares Expires 2028-09-25 F4 · derivative.exercise_date: The options will become exercisable as to 3,440 shares on each of 9/25/2019, 9/25/2020, 9/25/2021 and 3,441 shares on each of 9/25/2022 and 9/25/2023. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:49 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantCommon Stock | 18,734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001760173-19-000027 · primary_doc.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,734 F1 · price: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2 · price: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3 · price: Total includes 16,734 shares of restricted stock that will vest on; 2,717 shares on each of 9/25/2019 and 9/25/2020 and 2,718 shares on 9/25/2021, 2,861 shares on each of 2/26/2020 and 2/26/2021 and 2,860 shares on 2/26/2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 10:23 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 8,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001754464-19-000001 · primary_doc.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,734 F1 · shares: The Restricted Stock Award will become vested as to 2,861 shares on each of 2/26/2020 and 2/26/2021 and 2,860 shares on 2/26/2022. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 14:36 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantOption to purchase common stock $.001 par value · Derivative | 17,202 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001754464-18-000002 · primary_doc.xml · derivative · entry 2 Bartolucci Ryan M · CIK 0001754464 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,202 Underlying: Common Stock · 17,202 shares Expires 2028-09-25 F2 · derivative.exercise_date: The options will become exercisable as to 3,440 shares on each of 9/25/2019, 9/25/2020, 9/25/2021 and 3,441 shares on each of 9/25/2022, 9/25/2023. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 14:36 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 8,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001754464-18-000002 · primary_doc.xml · nonDerivative · entry 1 Bartolucci Ryan M · CIK 0001754464 · VP Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,152 F1 · shares: The Restricted Stock Award will become vested as to 2,717 shares on each of 9/25/2019 and 9/25/2020 and 2,718 shares on 9/25/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.